Assistant Professor, Urology, Indiana University School of Medicine
Urology
Dr. Timothy A. Masterson, MD
|
|
Give Review
Timothy Masterson practices Urology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received 13 awards: "2013 Best Reviewer- Oncology Articles", "Indiana's Best Doctors- Urology", "America's Top Surgeon", "Team Performance Award- Service Excellence", "America's Top Urologists", "Administrative Chief Clinical Fellow", "Who's Who in Medicine and Healthcare", "AUA/Threshold Gerald P. Murphy Scholar", "Earl F. Nation Resident Scholarship", "Willet Whitmore Memorial Scholarship", "Dr. Arnold Kunkler Scholarship for Academic Excellence", "Dr. Charles Preuss Medical Scholarship" and "Dean's Honor Roll". Dr. Timothy A. Masterson is a published MD. He published 49 publications, including: 'Risk of Recurrence for Clinical stage I and II Patients with Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.'
Publications
- The Evolution and Technique of Nerve-Sparing Retroperitoneal Lymphadenectomy.
- Risk of Recurrence for Clinical stage I and II Patients with Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
- Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications.
- Lymph node metastases in patients with urothelial carcinoma variants: influence of the Specific variant on nodal histology.
- Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular Cancer.
- Can radiologists and urologists reliably determine Renal mass histology using standard preoperative CT imaging?
- The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Good Risk Germ Cell Tumors.
- The changing reality of urothelial Bladder cancer: should non-squamous variant histology be managed as a distinct clinical entity?
- Critical analysis of the 2010 TNM classification in patients with lymph node-positive Bladder cancer: Influence of lymph node disease burden.
- Plasmacytoid variant urothelial Bladder cancer: Is it time to update the treatment paradigm?
- R.E.N.A.L. Nephrometry Scoring: How Well Correlated are Urologist, Radiologist, and Collaborator Scores?
- Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness.
- Plasmacytoid Bladder Cancer: Variant Histology With Aggressive Behavior and a New Mode of Invasion Along Fascial Planes.
- Re-operative Retroperitoneal Lymph Node Dissection for Metastatic Germ Cell Tumors: Analysis of Local Recurrence and Predictors of Survival.
- Incidence and Risk Factors of Parastomal Hernia in Patients Undergoing Radical Cystectomy and Ileal Conduit Diversion.
- Current and future biologic markers for Disease progression and relapse in testicular germ cell tumors: A review.
- EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary Bladder.
- Incidence, Histology, And Management Of Intraluminal Thrombus At Post-Chemotherapy Retroperitoneal Lymph Node Dissection.
- Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.
- Dyslipidemia, statins and prostate Cancer.
- Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site.
- Open vs. robotic-assisted radical Prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes.
- Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular Cancer.
- Tumor focality does not predict biochemical recurrence after radical prostatectomy in men with clinically localized prostate Cancer.
- Distinctive glycerophospholipid profiles of Human seminoma and adjacent normal tissues by desorption electrospray ionization imaging mass spectrometry.
- pT0 prostate Cancer after radical prostatectomy.
- How do you tell whether a change in surgical technique leads to a change in outcome?
- Nerve-sparing Prostatectomy and urinary function: a prospective analysis using validated quality-of-life measures.
- Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
- A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy.
- Risk stratification for positive lymph nodes in prostate Cancer.
- The association between total and positive lymph node counts, and disease progression in clinically localized prostate Cancer.
- Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate Cancer after radiotherapy.
- Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate Cancer: prognostic stratification of...
- Three-tiered nodal classification system for Bladder cancer: a new proposal.
- Multivariate statistical differentiation of Renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry.
- Pathological characterization of unifocal prostate Cancers in whole-mount radical prostatectomy specimens.
- Multivariate statistical identification of human Bladder carcinomas using ambient ionization imaging mass spectrometry.
- Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate Cancer.
- Intratubular germ cell neoplasms of the testis and bilateral Testicular tumors: clinical significance and management options.
- Outcomes after radical Prostatectomy in men receiving previous pelvic radiation for non-Prostate malignancies.
- A case of high-risk Penile epithelioid hemangioendothelioma.
- Advances in Robotic-Assisted Radical Prostatectomy over Time.
- The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate Cancer.
- Modified technique for neurovascular bundle preservation during radical Prostatectomy: association between technique and recovery of erectile function.
- Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular Cancer.
- Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical Prostatectomy.
- Cholesterol sulfate imaging in human prostate Cancer tissue by desorption electrospray ionization mass spectrometry.
Schools
Indiana University School of Medicine
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystometry
- Cystourethroplasty with Repair of Bladder Neck with Robotic Assistance
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Emblem Health
- First Health (Coventry Health Care) PPO
- HealthSmart
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- 2013 Best Reviewer- Oncology Articles
- Indiana's Best Doctors- Urology
- America's Top Surgeon
- Team Performance Award- Service Excellence
- America's Top Urologists
- Administrative Chief Clinical Fellow
- Who's Who in Medicine and Healthcare
- AUA/Threshold Gerald P. Murphy Scholar
- Earl F. Nation Resident Scholarship
- Willet Whitmore Memorial Scholarship
- Dr. Arnold Kunkler Scholarship for Academic Excellence
- Dr. Charles Preuss Medical Scholarship
- Dean's Honor Roll
Education
-
Memorial Sloan-Kettering Cancer Center -
University of Utah -
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1528227923 | |
| NPPES Provider LastName | MASTERSON | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 462025112 | |
| NPPES Provider State | IN | |
| Specialty Description | Urology | |
| Total Claim Count | 343.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 7.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528227923 |
| Last Name Of The Provider | MASTERSON |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Thomas A. Gardner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen R. Beck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew E. Moore, MD |
|
|
Dr. Ronald S. Boris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mauro J. Agnelneri Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily F. Jacobs, MD |
|
|
Dr. Niels-Erik B. Jacobsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander J. Tatem, MD |
|
|
Dr. Eric M. Deroo, MD |
|
|
James Wren |
|
|
Dr. Randall G. Rowland, MD
This Doctor is OpenDoctor Recommended.
|